FDA Inspection
Radienz Living LLCRadienz Living LLC – FDA Inspection, Jan 11, 2024
Record Details
This FDA Inspection record concerns Radienz Living LLC, with an inspection on January 11, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 50ce66dc-cef3-4b9f-a096-8e7af512dbc6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1228830
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Radienz Living LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 20, 2026 | Not classified | New York District Office | Colors and Cosmetics Technology |
| April 9, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 29, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Radienz Living LLC
- FDA Inspection 1304750 - 2026-04-20
- FDA Inspection 874751 - 2014-04-09
- FDA Inspection 699374 - 2010-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.